By
From the * Department of Immunology and Infectious Diseases, Harvard School of Public Health,
Boston, Massachusetts 02115; and the Department of Medicine, Harvard Medical School, Boston,
Massachusetts 02115
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
The differentiation of T helper (Th) cells is regulated by members of the signal transducer and
activator of transcription (STAT) family of signaling molecules. We have generated mice lacking both Stat4 and Stat6 to examine the ability of Th cells to develop in the absence of these
two transcription factors. Stat4, Stat6/
lymphocytes fail to differentiate into interleukin
(IL)-4-secreting Th2 cells. However, in contrast to Stat4
/
lymphocytes, T cells from Stat4,
Stat6
/
mice produce significant amounts of interferon (IFN)-
when activated in vitro. Although Stat4, Stat6
/
lymphocytes produce less IFN-
than IL-12-stimulated control lymphocytes, equivalent numbers of IFN-
-secreting cells can be generated from cultures of Stat4,
Stat6
/
lymphocytes activated under neutral conditions and control lymphocytes activated
under Th1 cell-promoting conditions. Moreover, Stat4, Stat6
/
mice are able to mount an in
vivo Th1 cell-mediated delayed-type hypersensitivity response. These results support a model
of Th cell differentiation in which the generation of Th2 cells requires Stat6, whereas a Stat4-independent pathway exists for the development of Th1 cells.
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Stimulation of naive T cells results in their differentiation
into effector cells with either a Th1 or Th2 phenotype.
As Th1 cells develop, a number of genetic changes occur,
including the loss of expression of IFN-R
chain (1, 2),
the induced expression of a modified form of P-selectin
glycoprotein ligand 1 (3, 4), and the priming for subsequent secretion of high levels of IFN-
and TNF-
after T
cell receptor stimulation (5). Similarly, as Th2 cells develop, there is a loss of expression of IL-12R
2 chain (6,
7), the induced expression of CCR3 (8), and the priming
to secrete a different panel of cytokines after activation, including IL-4, IL-5, IL-10, and IL-13 (5).
Several lines of evidence have led to a paradigm of Th
cell differentiation in which IL-12-mediated activation of
signal transducer and activator of transcription (Stat)4 and
IL-4-induced activation of Stat6 are critical for the generation of Th1 and Th2 cells, respectively. Mice harboring a
disrupted gene for either IL-4 (9, 10), IL-4R (11), or
Stat6 (12) fail to develop Th2 cells. Similarly, mice
lacking either IL-12 (15), IL-12R
1 (16), or Stat4 (17, 18)
demonstrate impaired Th1 cell function and, moreover, a
propensity for T cells to develop into Th2 cells (15, 17).
Although these observations suggest that STAT proteins
are important for the differentiation of Th cell subsets, they
do not rule out the possibility that STAT-independent
pathways may also exist. Stat6/
lymphocytes are completely impaired in their ability to generate IL-4-secreting
Th2 cells, suggesting that this differentiation pathway may
be entirely dependent on Stat6. In contrast, reduced levels
of IFN-
are produced by Stat4
/
lymphocytes when cultured under conditions that promote Th1 cell differentiation, suggesting that Stat4 is not absolutely required for
IFN-
expression. Additionally, the cytokine environment
during commitment to a Th cell lineage is clearly important, since IL-4 confers a dominant differentiation signal
which inhibits Th1 cell differentiation even in the presence
of IL-12 (19). These observations suggest that although
the impaired development of Th1 cells in Stat4
/
mice
may be due to the absence of Stat4, it may also be due in part to the preferential outgrowth of Th2 cells in response
to IL-4-activated Stat6. Since IL-4 both activates Stat6 and
interferes with the development of Th1 cells, we generated
double-deficient mice lacking Stat4 and Stat6 to examine
the ability of Th1 cells to develop in the absence of these
two signaling molecules. Although lymphocytes lacking
both Stat4 and Stat6 fail to differentiate into IL-4-secreting
Th2 cells, they do give rise to functional IFN-
-secreting
Th1 cells both in vitro and in vivo.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Mice.
Stat4, Stat6In Vitro Culture and Differentiation.
Differentiation of T cells and assay of cytokines were performed as described (12, 17). In brief, cells were activated with 1 µg/ml plate-bound anti-CD3. Where indicated, IL-12 was added at 1 ng/ml, and anti-IFN-Enzyme-linked Immunospot.
Cells were activated and cultured as above. After 1 wk, cells were restimulated with plate-bound anti-CD3 for 6 h and plated in dilution on anti-IFN-Delayed-type Hypersensitivity Reaction.
Male mice were immunized with 100 µg DNP-KLH (Calbiochem Corp., La Jolla, CA) emulsified in CFA (Sigma Chemical Co.), at the base of the tail. After 6 d, footpad thickness was measured using a spring-loaded caliper, and mice were challenged with 50 µg DNP-KLH in one foot and PBS in the contralateral appendage. Footpad thickness was measured blindly at 24 and 48 h after challenge. Specific swelling was determined by subtracting nonspecific swelling in the PBS-injected foot from antigen-induced swelling. At killing, popliteal and inguinal lymph nodes were removed and stimulated with 500 µg/ml DNP-KLH at a cell concentration of 106/ml for IFN- ![]() |
Results and Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
To further examine the mechanism by which Stat4 and
Stat6 regulate the differentiation of Th cell subsets, we generated Stat4, Stat6/
mice by intercrossing compound
heterozygotes. Double-deficient mice were produced at
the expected mendelian frequency and were grossly indistinguishable from their control littermates. All lymphoid
organs in Stat4, Stat6
/
mice had normal cellularity and
contained percentages of CD3+, CD4+, CD8+, and B220+
cells comparable to that seen in control littermates (data not shown).
Spleen cells from control, Stat4/
, Stat6
/
, and Stat4,
Stat6
/
mice were activated in vitro with plate-bound
anti-CD3 in the absence of exogenous cytokines or antibodies to determine their developmental potential. After 1 wk
in culture, cells were washed and restimulated with plate-bound anti-CD3 for 24 h. Supernatants were harvested, and IFN-
and IL-4 production were quantified by ELISA.
As expected, lymphocytes from control mice secrete both
IFN-
and IL-4 when activated in vitro under neutral conditions (Fig. 1). Consistent with previous results (12,
17, 18), Stat4
/
lymphocytes produce high levels of IL-4
but greatly reduced levels of IFN-
, whereas Stat6
/
lymphocytes secrete high levels of IFN-
but no IL-4. Stat4, Stat6
/
lymphocytes also do not produce IL-4 when activated in vitro, supporting the notion that Stat6 is essential
for the differentiation of Th2 cells. However, in contrast to
Stat4
/
lymphocytes, Stat4, Stat6
/
lymphocytes secrete
levels of IFN-
comparable to that produced by control or
Stat6
/
lymphocytes cultured under identical conditions.
Similar results were seen when cultures were either initiated with purified naive T cells obtained by selection of
CD4+ CD62L+ cells or when CD4+ T cells were purified
after the initial 7-d culture period and subsequently restimulated with anti-CD3 for 24 h (data not shown).
|
IL-4 signaling has a dominant effect over IL-12 stimulation in determining the outcome of Th cell differentiation
(21), and the results shown in Fig. 1 suggest that the presence of IL-4 signaling through Stat6 may impair the ability
of cells to develop the Th1 cell phenotype. To test this hypothesis, we attempted to recapitulate the IFN--secreting
phenotype of Stat4, Stat6
/
lymphocytes by activating
Stat6-expressing cells in vitro in the presence of cytokine-specific antibodies to eliminate STAT activation. In the absence of exogenous cytokines and antibodies, in vitro-activated Stat4, Stat6
/
lymphocytes secrete more IFN-
than Stat4
/
lymphocytes (Figs. 1 and 2 A). When Stat4
/
lymphocytes are activated in the presence of anti-IL-4, the
levels of IFN-
produced are nearly equal to those seen in
cultures of activated Stat4, Stat6
/
lymphocytes (Fig. 2
A). Similarly, when control cells are activated in the presence of anti-IL-4 plus anti-IL-12, the levels of IFN-
produced are indistinguishable from those seen in cultures of activated Stat4, Stat6
/
lymphocytes. These results are
consistent with a recent report demonstrating IFN-
production in the presence of neutralizing antibodies to both
IL-4 and IL-12 (23). Thus, substantial amounts of IFN-
can be produced by activated cells lacking Stat4 as long as
Stat6 is not activated in response to IL-4 stimulation.
|
IFN- has been suggested to have an important role in
priming cells for subsequent IFN-
production, although it
remains controversial whether it does so by a direct or indirect mechanism. Inclusion of anti-IFN-
to primary cultures of Stat4, Stat6
/
lymphocytes activated under neutral conditions did not affect the amount of IFN-
produced
by these cells after restimulation with anti-CD3 (Fig. 2 B).
This is in contrast to the lower amount of IFN-
produced
by control cells after restimulation when anti-IFN-
was
added in the primary culture. These results demonstrate
that the ability of Stat4, Stat6
/
lymphocytes to acquire an
IFN-
-secreting phenotype is not driven by endogenous
IFN-
, and are consistent with studies demonstrating that
the role of IFN-
in Th1 cell differentiation is indirect, upregulating IL-12R
2 expression so that cells become responsive to IL-12 stimulation (7).
IL-12 stimulation of activated T cells has been shown to
prime cells for high levels of IFN- production after subsequent restimulation (24). When compared with control
lymphocytes cultured under Th1 cell-promoting conditions (IL-12 plus anti-IL-4), the levels of IFN-
produced
by activated Stat4, Stat6
/
lymphocytes were decreased
four- to fivefold (Fig. 3 A). The amount of IFN-
produced by Stat4, Stat6
/
lymphocytes cultured in the presence of IL-12 does not increase over that seen when no exogenous cytokines are added (data not shown). The increased
amounts of IFN-
seen in cultures of Th1 cell-skewed
control lymphocytes relative to those seen in cultures of
Stat4, Stat6
/
lymphocytes could be the result of an increase either in the number of differentiated Th1 cells or in
the amount of IFN-
produced on a per cell basis. To distinguish between these possibilities, the number of IFN-
-secreting lymphocytes in these cultures was quantified
by enzyme-linked immunospot (ELISPOT). Spleen cells from control mice were differentiated into Th1 cells in
vitro by activation with plate-bound anti-CD3 in the presence of IL-12 and anti-IL-4 while spleen cells from Stat4
/
,
Stat6
/
, and Stat4, Stat6
/
mice were activated in the
absence of exogenous cytokines and antibodies. After 1 wk
in culture, CD4+ T cells were purified and restimulated with
plate-bound anti-CD3 for 6 h. Cells were then transferred
in dilution to plates containing anti-IFN-
(R4/6A2)-
coated Immobilon-P membranes at the bottom of the wells
and incubated overnight. In contrast to cultures of Stat4
/
lymphocytes where very few IFN-
-secreting cells were
detected, large numbers were seen in cultures of Th1 cell-
skewed control and unskewed Stat6
/
lymphocytes (Fig.
3 B). Strikingly, cultures of Stat4, Stat6
/
lymphocytes
had numbers of IFN-
-secreting cells comparable to that
seen in cultures of Th1 cell-skewed control and unskewed Stat6
/
lymphocytes. The spots produced in wells containing Th1 cell-skewed control cells were both larger and
darker than those seen in wells containing Stat4, Stat6
/
lymphocytes, supporting the conclusion that IL-12 stimulation and Stat4 activation lead to higher levels of IFN-
production on a per cell basis rather than a substantial increase in the number of differentiated Th1 cells.
|
Given that IFN--secreting cells could be generated
from Stat4, Stat6
/
mice in vitro, we sought to determine
whether Stat4, Stat6
/
mice could mount a Th1 cell response in vivo. To investigate this possibility, we examined
a classic Th1 cell-mediated immune response, the delayed-type hypersensitivity (DTH) reaction. Control, Stat4
/
,
and Stat4, Stat6
/
mice were immunized with 100 µg
DNP-KLH in CFA. 6 d later, mice were challenged by
footpad injection with either aqueous antigen or PBS as
control. All animals were killed 48 h after challenge, and
draining popliteal and inguinal lymph node cells were removed and restimulated in vitro with antigen. Lymphocytes from all three genotypes of mice produced a similar in
vitro proliferative response to antigen (Fig. 4 A), demonstrating comparable in vivo generation of antigen-specific
T cells. As expected, the levels of IFN-
produced after antigen stimulation in vitro varied among the groups. Stat4
/
lymphocytes produced <10% of the IFN-
secreted by
control cells (Fig. 4 B). Stat4, Stat6
/
lymphocytes also secreted less IFN-
than control cells, although the levels
were fourfold higher than that seen in cultures of Stat4
/
lymphocytes (Fig. 4 B). Finally, footpad thickness was measured before and 48 h after challenge, and specific swelling
was calculated (Fig. 4 C). Footpad swelling was significantly different in all three groups using the Kruskal-Wallis
test (P < 0.005). Furthermore, pairwise comparisons using
the Wilcoxon-Mann-Whitney test showed that swelling in
Stat4
/
mice was significantly reduced compared with
control (P < 0.005) and Stat4, Stat6
/
mice (P < 0.05).
Thus, functional Th1 cells capable of eliciting a DTH response can be generated in vivo in Stat4, Stat6
/
mice.
|
Our results demonstrate that the mechanisms that regulate the differentiation of Th1 and Th2 cells are not the
same. Previous studies have shown that Stat6 is essential for
the development of Th2 cells (12), presumably through
the transcriptional regulation of as yet unidentified genes
involved in the differentiation process. As IL-4-secreting
Th2 cells are not generated from Stat4, Stat6/
lymphocytes, Stat6 is required for their generation even in the absence of Stat4. In contrast, both Stat4-dependent and
-independent pathways appear to exist for the development
of IFN-
-producing Th1 cells. IL-12 stimulation and Stat4
activation lead to the differentiation of Th1 cells capable of
secreting large amounts of IFN-
. However, in the absence
of IL-4 and IL-12-mediated signals, the natural tendency
of CD4+ Th cells is to develop into IFN-
-secreting cells.
Thus, IL-4-mediated activation of Stat6, but not IL-12-
induced activation of Stat4, results in a differentiative signal
to Th cells. Mechanistically, this would explain the observation that IL-4 signaling has a dominant effect over IL-12
stimulation in determining the outcome of Th cell differentiation (21). Interestingly, a paradigm whereby the decision between two possible developmental pathways is dictated by the presence or absence of one signaling cascade
occurs in other differentiative processes, including sex determination. Sry expression activates a genetic program
which results in male gonadal development; female gonads
develop in its absence (25).
Although our results suggest that the ability of IL-12 to
promote Th1 differentiation may be indirect, by priming
for high levels of IFN- production which would inhibit
Th2 development and allow the outgrowth of Th1 cells,
they do not minimize the role of IL-12 and Stat4 activation
in normal Th cell development and function. Stat4 activation is clearly involved in regulating the production of
IFN-
and potentially other factors such as TNF-
that are
important in many Th1 cell-mediated responses. Nevertheless, the demonstration that functional Th1 cells can develop in the absence of Stat4 has important implications for the design of therapeutic strategies that aim to alter immune function by targeting STAT proteins in vivo.
![]() |
Footnotes |
---|
Address correspondence to Michael J. Grusby, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115. Phone: 617-432-1240; Fax: 617-432-0084; E-mail: grusby{at}mbcrr.harvard.edu Mark Kaplan's present address is Walther Oncology Center, Indiana University, Indianapolis, IN 46202.
Received for publication 10 March 1998 and in revised form 3 June 1998.
M.H. Kaplan is a Special Fellow and M.J. Grusby is a Scholar of the Leukemia Society of America. This work was supported by a grant from the National Institutes of Health to M.J. Grusby (RO1 AI-40171), and by a gift from the Mathers Foundation.We thank M. Gately for IL-12, Y. Han for technical assistance, J. Whalen for advice on DTH responses, R. Bosch for help with statistical analysis, and L. Glimcher and members of the laboratory for critical reading of the manuscript.
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
1. |
Bach, E.A.,
S.J. Szabo,
A.S. Dighe,
A. Ashkenazi,
M. Aguet,
K.M. Murphy, and
R.D. Schreiber.
1995.
Ligand-induced
autoregulation of IFN-![]() ![]() |
2. |
Pernis, A.,
S. Gupta,
K.J. Gollob,
E. Garfein,
R.L. Coffman,
C. Schindler, and
P. Rothman.
1995.
Lack of interferon-![]() ![]() ![]() |
3. | Austrup, F., D. Vestweber, E. Borges, M. Lohning, R. Brauer, U. Herz, H. Renz, R. Hallmann, A. Scheffold, A. Radbruch, and A. Hamann. 1997. P- and E-selectin mediate recruitment of T-helper-2 cells into inflamed tissues. Nature. 385: 81-83 [Medline]. |
4. |
Borges, E.,
W. Tietz,
M. Steegmaier,
T. Moll,
R. Hallmann,
A. Hamann, and
D. Vestweber.
1997.
P-selectin glycoprotein ligand-1 (PSGL-1) on T helper 1 but not on T helper 2 cells binds to P-selectin and supports migration into inflamed
skin.
J. Exp. Med.
185:
573-578
|
5. | Abbas, A.K., K.M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature. 383: 787-793 [Medline]. |
6. | Szabo, S.J., N.G. Jacobson, A.S. Dighe, U. Gubler, and K.M. Murphy. 1995. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity. 2: 665-675 [Medline]. |
7. |
Szabo, S.J.,
A.S. Dighe,
U. Gubler, and
K.M. Murphy.
1997.
Regulation of the interleukin (IL)-12R ![]() |
8. |
Sallusto, F.,
C.R. Mackay, and
A. Lanzavecchia.
1997.
Selective expression of the eotaxin receptor CCR3 by human T
helper 2 cells.
Science.
277:
2005-2007
|
9. | Kuhn, R., K. Rajewsky, and W. Muller. 1991. Generation and analysis of interleukin-4 deficient mice. Science. 254: 707-710 [Medline]. |
10. | Kopf, M., G. Le Gros, M. Bachmann, M.C. Lamers, H. Bluethmann, and G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature. 362: 245-248 [Medline]. |
11. |
Noben-Trauth, N.,
L.D. Shultz,
F. Brombacher,
J.F. Urban Jr.,
H. Gu, and
W.E. Paul.
1997.
An interleukin 4 (IL-4)-
independent pathway for CD4+ T cell IL-4 production is
revealed in IL-4 receptor-deficient mice.
Proc. Natl. Acad. Sci.
USA.
94:
10838-10843
|
12. | Kaplan, M.H., U. Schindler, S.T. Smiley, and M.J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity. 4: 313-319 [Medline]. |
13. | Shimoda, K., J. van Deursen, M.Y. Sangster, S.R. Sarawar, R.T. Carson, R.A. Tripp, C. Chu, F.W. Quelle, T. Nosaka, D.A.A. Vignali, et al . 1996. Lack of IL-4 induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature. 380: 630-633 [Medline]. |
14. | Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S.-I. Kashiwamura, K. Nakanishi, N. Yoshido, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature. 380: 627-630 [Medline]. |
15. |
Magram, J.,
S.E. Connaughton,
R.R. Warrier,
D.M. Carvajal,
C.-Y. Wu,
J. Ferrante,
C. Stewart,
U. Sarmiento,
D.A. Faherty, and
M.K. Gately.
1996.
IL-12-deficient mice are
defective in IFN![]() |
16. |
Wu, C.-Y.,
J. Ferrante,
M.K. Gately, and
J. Magram.
1997.
Characterization of IL-12 receptor ![]() ![]() ![]() |
17. | Kaplan, M.H., Y.-L. Sun, T. Hoey, and M.J. Grusby. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 382: 174-177 [Medline]. |
18. | Thierfelder, W.E., J.M. van Deursen, K. Yamamoto, R.A. Tripp, S.R. Sarawar, R.T. Carson, M.Y. Sangster, D.A.A. Vignali, P.C. Doherty, G.C. Grosveld, and J.N. Ihle. 1996. Requirement for Stat4 in interleukin-12 mediated responses of natural killer and T cells. Nature. 382: 171-174 [Medline]. |
19. |
Swain, S.L.,
A.D. Weinberg,
M. English, and
G. Huston.
1990.
IL-4 directs the development of Th2-like helper effectors.
J. Immunol.
145:
3796-3806
|
20. |
Hsieh, C.-S.,
A.B. Heimberger,
J.S. Gold,
A. O'Garra, and
K.M. Murphy.
1992.
Differential regulation of T helper phenotype development by interleukins 4 and 10 in an ![]() ![]() |
21. | Hsieh, C.-S., S.E. Macatonia, C.S. Tripp, S.F. Wolf, A. O'Garra, and K.M. Murphy. 1993. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 260: 547-549 [Medline]. |
22. |
Tanaka, T.,
J. Hu-Li,
R.A. Seder,
B.F. De St. Groth, and
W.E. Paul.
1993.
Interleukin 4 suppresses interleukin 2 and
interferon ![]() |
23. |
Hu-Li, J.,
H. Huang,
J. Ryan, and
W.E. Paul.
1997.
In differentiated CD4+ T cells, interleukin 4 production is cytokine-autonomous, whereas interferon ![]() |
24. |
Chan, S.H.,
B. Perussia,
J.W. Gupta,
M. Kobayashi,
M. Pospisil,
H.A. Young,
S.F. Wolf,
D. Young,
S.C. Clark, and
G. Trinchieri.
1991.
Induction of interferon ![]() |
25. | Koopman, P., J. Gubbay, N. Vivian, P. Goodfellow, and R. Lovell-Badge. 1991. Male development of chromosomally female mice transgenic for Sry. Nature. 351: 117-121 [Medline]. |